These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2444148)

  • 1. The subrenal capsule assay and gynecological cancer: five years of experience.
    Mäenpää J; Kangas L; Söderström KO; Grönroos M
    Ann Chir Gynaecol Suppl; 1987; 202():83-7. PubMed ID: 2444148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Responsiveness of gynecological malignancies to oral antitumor agents in subrenal capsule assay and individualization of oral adjuvant chemotherapy].
    Sekiguchi I; Suzuki M; Aida I; Tamada T; Nishida M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):437-42. PubMed ID: 2115558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subrenal capsule assay in choosing cytostatics for gynaecological tumours.
    Mäenpää J; Grönroos M; Kangas L
    Ann Chir Gynaecol Suppl; 1985; 199():28-30. PubMed ID: 3864390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumour effect of interferons, cytostatic drugs and their combinations in subrenal capsule assay (SRCA).
    Kangas L; Cantell K; Grönroos M; Mäenpää J; Perilä M
    Ann Chir Gynaecol Suppl; 1985; 199():60-3. PubMed ID: 2415035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The subrenal capsule assay for chemosensitivity testing of tumors. A review.
    Mäenpää J; Kangas L; Grönroos M
    Zentralbl Gynakol; 1988; 110(16):989-96. PubMed ID: 3055756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitotic index in the subrenal capsule assay as an indicator of the chemosensitivity of ovarian cancer.
    Suonio E; Lipponen P; Mäenpää J; Syrjänen K; Kangas L; Tuomisto L
    Cancer Chemother Pharmacol; 1997; 41(1):15-21. PubMed ID: 9443609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of chemosensitivity of gynecological cancer cell lines by the subrenal capsule assay].
    Kubo H; Ueda M; Maeda T; Yamada T; Yanagawa Y; Miyawaki Y; Misaki O; Ueki M; Sugimoto O
    Nihon Gan Chiryo Gakkai Shi; 1988 Apr; 23(4):837-43. PubMed ID: 3204308
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical application of subrenal capsule assay in ovarian cancer].
    Maeda K; Ushijima H; Shimamoto T; Shigematsu T; Kurano A; Watanabe Y; Jimi S; Okadome M; Mashiba H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):1896-902. PubMed ID: 2592813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I.
    Mäenpää J; Kangas L; Grönroos M
    Obstet Gynecol; 1985 Nov; 66(5):708-13. PubMed ID: 3932908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine subrenal capsule assay: prediction of chemoresponsiveness in head and neck cancer.
    Panje WR; McCormick KJ
    Laryngoscope; 1989 Jan; 99(1):41-9. PubMed ID: 2642583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural effects of alpha and gamma interferons and cytostatics on ovarian cancer cells in the subrenal capsule assay (SRCA).
    Söderström KO; Mäenpää J; Cantell K; Kangas L; Grönroos M
    Ann Chir Gynaecol Suppl; 1985; 199():38-43. PubMed ID: 3933399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subrenal capsule assay as a predictor of clinical response of ovarian cancer to chemotherapy: Part II.
    Mäenpää J
    Obstet Gynecol; 1985 Nov; 66(5):714-8. PubMed ID: 3903584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of the UFT sensitivity test using human urogenital cancers transplanted subcutaneously and under the subrenal capsule of nude mice].
    Murahashi I; Honda M; Mukae K; Hosoya Y; Takasaki E
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):231-5. PubMed ID: 3124766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the chemosensitivity test by human tumor clonogenic assay and subrenal capsule assay].
    Terashima M
    Nihon Geka Gakkai Zasshi; 1987 Nov; 88(11):1554-64. PubMed ID: 3431536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Applicability of the subrenal capsule assay (SRCA) in primary breast carcinoma].
    Gerber B; Richter D; Rohde E; Wilken H; Rudolf K; Kasch R
    Arch Geschwulstforsch; 1989; 59(2):85-91. PubMed ID: 2541670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of subrenal capsule assay (SRC) for clinical cancers].
    Akao S; Iwami N; Oya M; Terada H; Sasaki K; Ishikawa H; Kiumi F
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):607-13. PubMed ID: 8678520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of the 6-day subrenal capsule assay for sensitivity testing of antineoplastic chemotherapy in oral mucosa carcinoma].
    Fröhlich M; Rositzka R; Neubauer B
    Zahn Mund Kieferheilkd Zentralbl; 1989; 77(5):427-32. PubMed ID: 2529712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The subrenal capsule assay in selecting chemotherapy for ovarian cancer: a prospective randomized trial.
    Mäenpää JU; Heinonen E; Hinkka SM; Karnani P; Klemi PJ; Korpijaakko TA; Kuoppala TA; Laine AM; Lähde MA; Nuoranne EK
    Gynecol Oncol; 1995 Jun; 57(3):294-8. PubMed ID: 7774832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subrenal capsule assay in selection of chemotherapy after operation for recurrent ovarian cancer.
    Venesmaa P; Ylikorkala O
    Br J Cancer; 1991 Jan; 63(1):84-6. PubMed ID: 1899195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
    Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
    Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.